Insulin aspart biosimilar(HEC Pharm)

N/A

Report date: 2025/03/07 17:34:31

Base Information

Drug NameInsulin aspart biosimilar(HEC Pharm)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar

Mechanisms of ActionOrnithine decarboxylase stimulantsProtein-tyrosine kinases inhibitorsPhosphokinases stimulants

TargetsProtein-tyrosine kinasesOrnithine decarboxylasePhosphokinases

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHec Pharm Usa Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus

Inactive IndicationsN/A

ATC CodeN/A